FailedDiscontinued

Tebapivat (AG-946)

Myelodysplastic syndrome

AGIOAgios Pharmaceuticals Inc.

Expected catalystTBA

Catalyst overview

Event details

Drug or asset: Tebapivat (AG-946)
Development stage: Failed
Event type: Discontinued
Indication: Myelodysplastic syndrome

Research summary

What is being tracked?

This catalyst tracks a Failed discontinued for Tebapivat (AG-946) in Myelodysplastic syndrome. The expected timing is based on the latest available company guidance and may change.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

Tebapivat (AG-946)

Event details

What is being tracked?

Primary source

Related pipeline programs

PYRUKYND (Mitapivat)

PYRUKYND (Mitapivat)

AG-181

Tebapivat